SOURCE: DSM N.V.

December 14, 2010 01:21 ET

DSM provides 2009 and Q1-Q3 2010 comparative figures

HEERLEN, NETHERLANDS--(Marketwire - December 14, 2010) -


Royal DSM N.V. today provides the investment community with comparative quarterly figures for 2009 and the first nine months of 2010.

These comparative figures are a result of the today announced divestment of Keltan®, and the previously announced and finalized divestment of Thermoplastic Elastomers (Sarlink®). Both businesses formed the business group DSM Elastomers. Thermoplastic Elastomers (Sarlink®) was already classified as held for sale in the balance sheet as per September 30, 2010 but did not represent a discontinued operation.

The comparative figures reflect the reclassification of the complete business group DSM Elastomers from the Base Chemicals and Materials cluster to assets held for sale and discontinued operations. It also reflects the reclassification of the remaining activities of the Base Chemicals and Materials cluster to Other activities.

With the announced divestment of the remaining part of DSM Elastomers (Keltan®), DSM will stop to report on the Base Chemicals and Materials cluster, as announced earlier.

The comparative figures can be found in the annex to this press release and can also be downloaded from the Investors section on the DSM corporate website, www.dsm.com.

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com .



Restatement-pdf: http://hugin.info/130663/R/1471965/408586.pdf

Press release-pdf: http://hugin.info/130663/R/1471965/408585.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE

[HUG#1471965]

Contact Information

  • For more information:

    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    fax +31 (0) 45 5740680
    e-mail Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 45 5782595
    e-mail Email Contact